Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: An analysis of nationwide data for 2000-2009

Journal of the Formosan Medical Association

Volumn 111, Issue 11, 2012, Pages 625-636

  Tseng, Li Nien ^a,b   Tseng, Yao Hsien ^a   Jiang, Yi Der ^c   Chang, Chia Hsuin ^c,d   Chung, Ching Hu ^e   Lin, Boniface J ^f   Chuang, Lee Ming ^c,d   Tai, Tong Yuan ^g   Sheu, Wayne H H ^a,b,h  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e TZU CHI UNIVERSITY   (Taiwan)

^f St Mary's Hospital   (Taiwan)

^g Taipei Jen Chi Relief Institute   (Taiwan)

^h NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cardiovascular disease; Cerebrovascular disease; Diabetes; Dyslipidemia; Microvascular diseases

Indexed keywords

ADULT; AGED; ARTICLE; BLINDNESS; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMORBIDITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIALYSIS; DYSLIPIDEMIA; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; RISK FACTOR; TAIWAN;

ADULT; AGE DISTRIBUTION; AGED; CEREBROVASCULAR DISORDERS; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; TAIWAN;

EID: 84872420829     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2012.09.010     Document Type: Article

References (36)

1. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
2. Chang C.H., Shau W.Y., Jiang Y.D., Li H.Y., Chang T.J., Sheu W.H., et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med 2010, 27:636-643.
3. U.K. Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997, 20:1683-1687.
4. Saydah S.H., Fradkin J., Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004, 291:335-342.
5. Vijayaraghavan K. Treatment of dyslipidemia in patients with type 2 diabetes. Lipids Health Dis 2010, 9:144-155.
6. Chiu Y.H., Wu S.C., Tseng C.D., Yen M.F., Chen T.H. Progression of pre-hypertension, stage 1 and 2 hypertension (JNC 7): a population-based study in Keelung, Taiwan (Keelung Community-based Integrated Screening No. 9). J Hypertens 2006, 24:821-828.
7. Long A.N., Dagogo-Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens (Greenwich) 2011, 13:244-251.
8. Rastenyle D. Epidemiology of macrovascular disease and hypertension in diabetes mellitus. International textbook of diabetes mellitus 1997, 146. John Wiley & Sons, New York, Chichester, England. 2nd ed. K.G.M.M. Alberti, P. Zimmet, R.A. DeFronzo (Eds.).
9. Wen C.P., Tsai S.P., Chung W.S. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med 2008, 148:258-267.
10. Lin C.C., Lai M.S., Syu C.Y., Chang S.C., Tseng F.Y. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc 2005, 104:157-163.
11. Dai D.F., Hwang J.J., Chen C.L., Chiang F.T., Lin J.L., Hsu K.L., et al. Effect of physical activity on the prevalence of metabolic syndrome and left ventricular hypertrophy in apparently healthy adults. J Formos Med Assoc 2010, 109:716-724.
12. Farmer J.A. Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials. Curr Diab Rep 2008, 8:71-77.
13. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:434-444.
14. Lin S.D., Tu S.T., Hsu S.R., Lin K.C., Sheu W.H. Characteristics predicting dyslipidemia in drug-naïve type 2 diabetes patients. J Chin Med Assoc 2006, 69:404-408.
15. Yu N.C., Su H.Y., Tsai S.T., Lin B.J., Shiu R.S., Hsieh Y.C., et al. ABC control of diabetes: survey data from National Diabetes Health Promotion Centers in Taiwan. Diabetes Res Clin Pract 2009, 84:194-200.
16. International Diabetes Federation, IDF Diabetes Atlas. ; 2011. http://www.diabetsatlas.org.
17. Chan J.C., Chan S.P., Deerochanawong C., Go R.T., Lee K.O., Ma R.C., et al. Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: what we know and don't know. Diabetes Res Clin Pract 2011, 94:1-13.
18. So W.Y., Raboca J., Sobrepena L., Yoon K.H., Deerochanawong C., Ho L.T., et al. Comprehensive risk assessments of diabetic patients from seven Asian countries: the Joint Asia Diabetes Evaluation (JADE) program. J Diabetes 2011, 3:109-118.
19. Xu Z.R., Wang Y.Z., Jing H., Liu Y.J., Huang L.J., Wu C.R., et al. [Lipids disorder, macrovascular diseases, and insulin resistance in Chinese diabetic patients]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002, 24:457-461. [article in Chinese].
20. Cheng S.H., Lee T.T., Chen C.C. A longitudinal examination of a pay-for-performance program for diabetes care: evidence from a natural experiment. Med Care 2012, 50:109-116.
21. Chiang C.W., Chiu H.F., Chen C.Y., Wu H.L., Yang C.Y. Trends in the use of lipid-lowering drugs by outpatients with diabetes in Taiwan, 1997-2003. Pharmacoepidemiol Drug Saf 2008, 17:62-69.
22. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
23. Su T.C., Bai C.H., Chang H.Y., You S.L., Chien K.L., Chen M.F., et al. Evidence for improved control of hypertension in Taiwan: 1993-2002. J Hypertens 2008, 26:600-606.
24. Chien K.L., Hsu H.C., Sung F.C., Su T.C., Chen M.F., Lee Y.T. Incidence of hypertension and risk of cardiovascular events among ethnic Chinese: report from a community-based cohort study in Taiwan. J Hypertens 2007, 25:1355-1361.
25. Howard B.V., Lee E.T., Cowan L.D., Fabsitz R.R., Howard W.J., Oopik A.J., et al. Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. Am J Epidemiol 1995, 142:254-268.
26. Howard B.V., Cowan L.D., Go O., Welty T.K., Robbins D.C., Lee E.T. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 1998, 21:1258-1265.
27. Chen I.C., Chao T.H., Tsai W.C., Li Y.H. Rosiglitazone reduces plasma levels of inflammatory and hemostatic biomarkers and improves global endothelial function in habitual heavy smokers without diabetes mellitus or metabolic syndrome. J Formos Med Assoc 2010, 109:113-119.
28. Gilman S. Advances in neurology (2). N Engl J Med 1992, 326:1671-1676.
29. Adams H.P., Putman S.F., Kassell N.F., Torner J.C. Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol 1984, 41:1033-1035.
30. Megherbi S.E., Milan C., Minier D., Couvreur G., Osseby G.V., Tilling K., et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke 2003, 34:688-694.
31. Dawber T.R., Kannel W.B., Lyell L.P. An approach to longitudinal studies in a community: the Framingham Study. Ann NY Acad Sci 1963, 107:539-556.
32. Rodriguez B.L., D'Agostino R., Abbott R.D., Kagan A., Burchfiel C.M., Yano K., et al. Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: a comparison of incidence and risk factor effects. Stroke 2002, 33:230-236.
33. Putaala J., Metso A.J., Metso T.M., Konkola N., Kraemer Y., Haapaniemi E., et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke 2009, 40:1195-1203.
34. Fromm A., Waje-Andreassen U., Thomassen L., Naess H. Comparison between ischemic stroke patients <50 years and ≥50 years admitted to a single centre: the Bergen Stroke Study. Stroke Res Treat 2011, 2011:183256.
35. Mohler E.R. Peripheral arterial disease: identification and implications. Arch Intern Med 2003, 163:2306-2314.
36. Tseng C.H. Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients. Angiology 2003, 54:331-338.